| Drug Name |
Dicyclomine |
| Drug ID |
BADD_D00659 |
| Description |
Dicyclomine is a muscarinic M1, M3, and M2 receptor antagonist as well as a non-competitive inhibitor of histamine and bradykinin used to treat spasms of the intestines seen in functional bowel disorder and irritable bowel syndrome.[A6556,A182555,A234659,L7967] Though it is commonly prescribed, its recommendation may have been based on a small amount of evidence and so its prescription is becoming less favourable.[L7982]
Dicyclomine was granted FDA approval on 11 May 1950.[L7967] |
| Indications and Usage |
Dicyclomine is indicated for the treatment of functional bowel disorder and irritable bowel syndrome.[L7967] |
| Marketing Status |
approved |
| ATC Code |
A03AA07 |
| DrugBank ID |
DB00804
|
| KEGG ID |
D07820
|
| MeSH ID |
D004025
|
| PubChem ID |
3042
|
| TTD Drug ID |
D07XJM
|
| NDC Product Code |
Not Available |
| UNII |
4KV4X8IF6V
|
| Synonyms |
Dicyclomine | Dicycloverin | Dicyclomine Hydrochloride | Hydrochloride, Dicyclomine | Merbentyl | Bentylol | Spascol | Di-Spaz | Di Spaz | Dibent | Diclomin | Lomine | OR-Tyl | OR Tyl | Bentyl | Di-Cyclonex | Di Cyclonex |
